ProKidney Plans to Use Proceeds for Clinical Trial Costs, R&D, Continued Investment, General Corporate Purposes >PROK
ProKidney Plans to Use Proceeds for Clinical Trial Costs, R&D, Continued Investment, General Corporate Purposes >PROK
ProKidney計劃將收益用於臨床試驗費用、研發、持續投資、一般企業用途>> PROK
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊